Updating medicine ingredient names - list of affected ingredients

We updated some medicine ingredient names used in Australia to align with names used internationally.

Active ingredients

Changes to active ingredients include:

• Adrenaline and noradrenaline
• Dual labelling
• Hydration change only
• Minor spelling changes
• Other minor changes
• Other significant changes

Adrenaline and noradrenaline

Adrenaline and noradrenaline remain as the approved names in Australia. There is no intent to move to using epinephrine and norepinephrine as the new ingredient names.

Instead, medicines containing adrenaline and noradrenaline will include the international names epinephrine and norepinephrine on labels and information leaflets. By including this information on labels indefinitely, we hope to reduce confusion for health professionals and consumers.

Dual labelling

Dual labelling: these ingredients will need to show the dual labelled name on the product label until the end of the relevant dual labelling period, before changing to the new name. For more information see Dual labelled medicine ingredient names start the transition to sole names on 30 April 2023.

Active ingredient changes

You can search this table by active ingredient name or by change type. You can also sort by clicking on the column headings.

Excipient ingredient changes

You can search this table by excipient ingredient name. You can also sort by clicking on the column headings.

Version history